semaglutide half-life Chemical Strategies for Extension of Biopharmaceuticals: Lipidation and Its Alternatives Approaches for half-life extension of

tirzepatide: Weekly dosing, injections, pills and key differences Semaglutide and tirzepatide are best known as once-weekly injections, but semaglutide has expanded beyond the needle

Dementia was the seventh leading cause of death globally in 2019

In 2024, semaglutide 2.4 mg (Wegovy) received FDA approval for cardiovascular risk reduction in adults with established cardiovascular disease and either overweight or obesity, based on the SELECT trial

But recent studies have also suggested semaglutide and other GLP-1 receptor agonists might have anti-inflammatory properties, and could even protect against cartilage wear and tear